Lupin Ltd. Dominates Largecap Pharma Industry with Impressive Stock Performance
Lupin Ltd., a leading pharmaceutical company, has been making headlines for its impressive stock performance. Its stock reached a 52-week high of Rs. 1441.75 on January 19, 2024, and has been given a 'Strong Buy' rating by MarketsMojo. The company has shown consecutive gains and is trading higher than its moving averages, outperforming the Sensex with a 1-year performance of 88.18%.
Lupin Ltd., a leading pharmaceutical company in the largecap industry, has been making headlines recently with its impressive stock performance. On January 19, 2024, the company's stock price reached a 52-week high of Rs. 1441.75, showcasing its strong growth and potential in the market.
According to MarketsMOJO, a leading stock analysis platform, Lupin's stock has been given a 'Strong Buy' rating, making it a top pick for investors. The company has also been listed as a part of the "Reliable Performers" on MarketsMOJO since November 10, 2023, further solidifying its position in the market.
In terms of price performance, Lupin has been inline with the sector and has shown consecutive gains for the last 3 days, with a 3.38% increase in returns. The stock has also been trading in a narrow range of Rs. 8.85, indicating stability and consistency in its performance.
Moreover, Lupin is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, showcasing its strong momentum and positive trend in the market.
In comparison to the Sensex, Lupin has outperformed with a 1-year performance of 88.18%, while the Sensex has only shown a 17.94% increase. This further highlights the company's strong growth and potential in the largecap industry.
Overall, Lupin Ltd. has been making impressive strides in the market with its consistent performance and positive outlook. With its recent 52-week high and strong ratings from MarketsMOJO, the company continues to be a top choice for investors in the pharma industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
